Extra firms around the globe proceed turning to Beckman Coulter Life Sciences, a world chief in laboratory automation and innovation, for his or her subsequent technology sequencing (NGS) wants with the Biomek NGeniuS System. The corporate continues constructing a strong demonstrated utility library because it publicizes an utility growth settlement with Pillar Biosciences, which makes a speciality of growing and commercializing IVD & RUO NGS testing options that assist analysis to optimize choice of precision therapies for most cancers sufferers, from tumor profiling to remedy choice, and recurrence monitoring.
Picture Credit score: Beckman Coulter Life Sciences
Within the historically labor-intensive technique of NGS library development, the Biomek NGeniuS System cuts via the litter by slashing handbook steps with an intuitive and easy-to-use automation resolution. Palms-on time is lowered by improvements that embody a reagent enter carousel to attenuate the handbook switch of reagents, together with an built-in thermal cycler and labware transport system.
With the worldwide NGS market projected to develop to almost $9.2 billion in 2022, demand is anticipated to extend for options to supply important help to NGS labs.
As this market section continues to develop, Beckman Coulter Life Sciences is prepared and uniquely positioned to assist labs of all sizes speed up solutions for necessary scientific analysis. This partnership with Pillar Biosciences additional showcases the energy and attraction of our open chemistry idea that is unique to the Biomek NGeniuS System. With a major discount in handbook and error-prone steps within the library prep course of, we’re excited to pioneer workflows that enable lab employees to as an alternative concentrate on their ardour for analysis and their imaginative and prescient for the way forward for molecular diagnostics”
Amy Yoder, Director of Genomics Product Administration
As a part of the partnership settlement, Pillar Biosciences will develop purposes particularly designed for the Biomek NGeniuS System*, which shall be accessible to all customers by way of a first-of-its-kind digital utility library.
“The power of laboratories, hospitals, and healthcare programs to assist analysis for correct, environment friendly, and cost-effective Subsequent Era Sequencing applied sciences and diagnostic testing on the native degree with speedy turnaround time, affords the promise to significantly enhance the long run state of most cancers care,” mentioned Randy Prichard, CEO of Pillar Biosciences. “Our partnership with Beckman Coulter Life Sciences to develop and supply automated workflow purposes on the Biomek NGeniuS System for our portfolio of oncoRevealTM kitted options, which leverage Pillar’s proprietary single-tube enrichment chemistry, SLIMamp®, reaffirms Pillar’s international dedication to serving to to drive the localization of NGS testing and enabling higher Determination MedicineTM for everybody, in every single place.”
Launched in June of 2022, the Biomek NGeniuS System gives the last word flexibility, with unique software program that permits any batch dimension, from 4 to 24 samples, to be arrange from wherever and monitored remotely from a Google Chrome or Microsoft Edge-enabled pc. The workstation additionally reduces loading errors by combining a classy optical analytics know-how – Dynamic DeckOptix system – to supply customers with real-time suggestions on labware placement. Extra product data could be discovered at becls.co/ngenius.
About Beckman Coulter Life Sciences
life sciences. Analysis. Precision manufacturing. In case your life’s calling is in any of those or associated fields, you have to know Beckman Coulter Life Sciences. Our mission is to empower these in search of solutions to life’s necessary scientific and healthcare questions. Since 1935, the Beckman title has been synonymous with applied sciences that simplify and automate complicated biomedical testing. A long time later, our international group additionally got here to embody the scientific legacy of the Coulter title.
At the moment, Beckman Coulter Life Sciences is a trusted, worldwide useful resource for instruments to assist optimize analysis and manufacturing effectivity. centrifuges Particle counters/analyzers. Automated liquid handlers. Move cytometers. Genomic reagents. All these merchandise—and plenty of extra—proceed to make a distinction in folks’s lives by enhancing the productiveness of devoted scientists, high quality management specialists and others. Wherever folks want solutions, from prestigious universities and main pharmaceutical firms, to small biotech startups, meals/beverage and electronics manufacturing amenities, you’ll find Beckman Coulter Life Sciences. For extra particulars, go to beckman.com/contact-us
About Pillar Biosciences
Pillar Biosciences is the chief in Determination Medication™, which is the utilization of extremely correct and delicate next-generation sequencing (NGS) testing know-how to generate knowledge that optimizes choice of precision therapies for most cancers sufferers, from tumor profiling to remedy choice, and recurrence monitoring. Pillar’s NGS testing options, together with the FDA-approved oncoReveal™ Dx Lung and Colon Most cancers Assay, is powered by the Firm’s proprietary SLIMamp® and PiVAT® applied sciences, and decentralizes the testing course of, decreasing diagnostic prices and enhancing entry and effectivity of complicated NGS testing for pathologists, prescribers, and sufferers worldwide.
The Firm has greater than 20 NGS testing merchandise accessible in IVD or RUO codecs, and a number of other others in numerous levels of growth, together with a pan-cancer oncoReveal™ CDx assay, and two liquid biopsy choices. Pillar’s patented applied sciences have been proven to supply correct and actionable knowledge in as little as 48 hours, which permits physicians to pick out acceptable therapies and monitor the affected person’s response. Pillar Biosciences has operations in Natick, MA and Shanghai, China. For extra data, go to www.pillarbiosci.com.
